Table II.
Response to cancer treatment and side-effects following therapy in 53 patients with nasopharyngeal carcinoma.
| Clinical data | IMRT | 2D-CRT | χ2 value | P-value |
|---|---|---|---|---|
| Total | 24 | 29 | ||
| Cancer treatment | ||||
| response | ||||
| Tumor regression | 16 | 7 | 9.67 | 0.00 |
| Tumor residue | 8 | 22 | ||
| Radiation myelitis | ||||
| grade | ||||
| 0 | 22 | 28 | 0.58 | 0.45 |
| 1 | 2 | 1 | ||
| Dry mouth | ||||
| Degree 0–1 | 17 | 10 | 7.11 | 0.01 |
| Degree 2 | 6 | 14 | ||
| Degree 3 | 1 | 5 | ||
| Oral and pharyngeal | ||||
| mucositis grade | ||||
| 0–1 | 4 | 3 | 0.13 | 0.72 |
| 2 | 8 | 9 | ||
| ≥3 | 12 | 17 | ||
| Myelosuppression | ||||
| grade | ||||
| 0 | 5 | 7 | 0.14 | 0.71 |
| 1 | 11 | 14 | ||
| 2 | 6 | 5 | ||
| 3 | 2 | 3 |
IMRT, intensity-modulated radiotherapy; 2D-CRT, two-dimensional conventional radiotherapy.